Nomogram to predict pathologic complete response in HER2-positive breast cancer treated with neoadjuvant systemic therapy

BACKGROUND: Pathologic complete response (pCR) is associated with improved survival outcomes in patients with HER2-positive primary breast cancer. We developed a nomogram to predict the probability of pCR rates by using oestrogen receptor (ER) expression, progesterone receptor (PR) expression and HE...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujii, Takeo, Kogawa, Takahiro, Wu, Jimin, Sahin, Aysegul A, Liu, Dian D, Chavez-MacGregor, Mariana, Giordano, Sharon H, Raghavendra, Akshara, Murthy, Rushmy K, Tripathy, Debu, Shen, Yu, Yamal, Jose-Miguel, Ueno, Naoto T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5318977/
https://www.ncbi.nlm.nih.gov/pubmed/28081544
http://dx.doi.org/10.1038/bjc.2016.444

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5318977/
https://www.ncbi.nlm.nih.gov/pubmed/28081544
http://dx.doi.org/10.1038/bjc.2016.444

Ejemplares similares